Richard M Pastor

Title: Richard M Pastor: Innovator in NLRP3 Modulation

Introduction

Richard M Pastor is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that modulate the NLRP3 inflammasome. His work is crucial for advancing treatments for various NLRP3-dependent disorders.

Latest Patents

Richard M Pastor holds a patent for "Sulfonimidamide compounds as NLRP3 modulators." This patent describes compounds of Formula (I), Formula (I-A), and Formula (I-B), along with their solvates, tautomers, and pharmaceutically acceptable salts. The patent further details methods for inhibiting NLRP3 using these compounds, as well as compositions useful in treating disorders associated with NLRP3.

Career Highlights

Richard M Pastor is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has allowed him to collaborate with other talented professionals in the field.

Collaborations

Some of Richard's coworkers include Paul Gibbons and Kwong Wah Lai, who contribute to the collaborative environment that fosters innovation and research excellence at Genentech.

Conclusion

Richard M Pastor's contributions to the field of NLRP3 modulation highlight his role as an important inventor in the pharmaceutical industry. His patent and ongoing work at Genentech demonstrate his commitment to advancing medical science and improving patient outcomes.